ArticleMolecular medicine (Cambridge, Mass.)2021

Therapeutic administration of etoposide coincides with reduced systemic HMGB1 levels in macrophage activation syndrome.

Karin Palmblad et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.